Cellular delivery and activation polypeptide-nucleic acid complexes

Details for Australian Patent Application No. 2004204456 (hide)

Owner Invitrogen Corporation

Inventors Dalby, Brian; Bennett, Robert P.

Agent Houlihan2

Pub. Number AU-A-2004204456

PCT Pub. Number WO2004/063342

Priority 60/438,778 09.01.03 US

Filing date 9 January 2004

Wipo publication date 29 July 2004

International Classifications

C12N 015/87 Mutation or genetic engineering - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Event Publications

11 August 2005 PCT application entered the National Phase

  PCT publication WO2004/063342 Priority application(s): WO2004/063342

6 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004204462-Dual expression vector system for antibody expression in bacterial and mammalian cells

2004204446-Method of detecting antibiotic resistance in microorganisms